We are live on ! Find out more
OLA

Oliver Luxxe Assets Portfolio holdings

AUM $680M
1-Year Est. Return 47.51%
This Fund
S&P 500
This Quarter Est. Return
+18.61%
1 Year Est. Return
+47.51%
3 Year Est. Return
+136.97%
5 Year Est. Return
+214.93%
10 Year Est. Return
+612.54%
AUM
$680M
AUM Growth
+$12.5M
Cap. Flow
-$83.6M
Cap. Flow %
-12.28%
Top 10 Hldgs %
19.1%
Holding
216
New
16
Increased
34
Reduced
132
Closed
17

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$8.52M
2
NRG icon
NRG Energy
NRG
+$6.36M
3
SNX icon
TD Synnex
SNX
+$5.16M
4
SYK icon
Stryker
SYK
+$3.97M
5
DE icon
Deere & Co
DE
+$3.68M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$6.62M
2
CRM icon
Salesforce
CRM
+$5.9M
3
EL icon
Estee Lauder
EL
+$5M
4
SANM icon
Sanmina
SANM
+$3.63M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.59M

Sector Composition

Rank Sector Weight
1 Financials 16.71%
2 Industrials 16.07%
3 Technology 15.33%
4 Miscellaneous 11.59%
5 Healthcare 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJR icon
126
iShares Core S&P Small-Cap ETF
IJR
$110B
$1.53M 0.22%
10,300
-142
-1% -$19.5K
BSCV icon
127
Invesco BulletShares 2031 Corporate Bond ETF
BSCV
$1.8B
$1.52M 0.22%
92,889
+32,224
+53% +$530K
RSP icon
128
Invesco S&P 500 Equal Weight ETF
RSP
$99.6B
$1.51M 0.22%
7,091
-506
-7% -$104K
AZZ icon
129
AZZ Inc
AZZ
$4.21B
$1.5M 0.22%
9,702
-8,434
-47% -$1.2M
RUSHA icon
130
Rush Enterprises Class A
RUSHA
$5.95B
$1.48M 0.22%
30,504
-15,075
-33% -$709K
AUB icon
131
Atlantic Union Bankshares
AUB
$5.84B
$1.46M 0.22%
34,599
-29,743
-46% -$1.14M
AMRX icon
132
Amneal Pharmaceuticals
AMRX
$6.07B
$1.46M 0.21%
84,217
-72,068
-46% -$988K
BSCR icon
133
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
$4.58B
$1.4M 0.21%
71,255
-12,661
-15% -$249K
CPRI icon
134
Capri Holdings
CPRI
$1.54B
$1.36M 0.2%
73,087
-56,721
-44% -$1.09M
PSMT icon
135
Pricesmart
PSMT
$5.37B
$1.35M 0.2%
6,893
-5,941
-46% -$991K
VSXY
136
Victoria's Secret
VSXY
$6.01B
$1.34M 0.2%
16,101
-13,387
-45% -$802K
BSCU icon
137
Invesco BulletShares 2030 Corporate Bond ETF
BSCU
$2.71B
$1.34M 0.2%
80,501
+16,403
+26% +$274K
INVA icon
138
Innoviva
INVA
$1.54B
$1.34M 0.2%
58,957
-26,003
-31% -$595K
EPD icon
139
Enterprise Products Partners
EPD
$84.1B
$1.34M 0.2%
36,331
-9,595
-21% -$362K
GVA icon
140
Granite Construction
GVA
$5.3B
$1.32M 0.19%
8,322
-7,105
-46% -$965K
MO icon
141
Altria Group
MO
$115B
$1.27M 0.19%
17,610
WFRD icon
142
Weatherford International
WFRD
$6.86B
$1.22M 0.18%
14,909
-7,067
-32% -$717K
PFS icon
143
Provident Financial Services
PFS
$3.09B
$1.18M 0.17%
49,837
-42,681
-46% -$959K
SHY icon
144
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
$1.15M 0.17%
13,962
+3,652
+35% +$300K
GPOR icon
145
Gulfport Energy Corp
GPOR
$3.17B
$1.09M 0.16%
6,409
-5,147
-45% -$929K
LAZ icon
146
Lazard
LAZ
$4.39B
$1.08M 0.16%
25,638
-21,927
-46% -$1M
BSCQ icon
147
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
$3.46B
$930K 0.14%
47,610
-3,075
-6% -$60.1K
BSCW icon
148
Invesco BulletShares 2032 Corporate Bond ETF
BSCW
$1.53B
$881K 0.13%
42,960
-1,903
-4% -$39.2K
CAT icon
149
Caterpillar
CAT
$374B
$876K 0.13%
823
-439
-35% -$386K
THC icon
150
Tenet Healthcare
THC
$21.3B
$753K 0.11%
4,024
-1,150
-22% -$211K

Similar funds

Oliver Luxxe Assets's Q2 2026 Portfolio in Review

As of Q2 2026, Oliver Luxxe Assets held 216 positions worth $680M, up 1.9% from $668M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Oliver Luxxe Assets withdrew a net $83.6M in Q2 2026, closing 17 positions and reducing 132 holdings. Its most notable exit was HCA Healthcare, an estimated $6.62M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

Against the trend, Oliver Luxxe Assets opened a new position in AstraZeneca worth $8.52M.

  • Oliver Luxxe Assets's largest Q2 2026 buy was AstraZeneca: 45,272 shares worth $8.52M.
  • Oliver Luxxe Assets added most to TE Connectivity in Q2 2026, an estimated $2.72M increase.
  • Oliver Luxxe Assets's biggest Q2 2026 reduction was Sanmina, cutting an estimated $3.63M.
  • Oliver Luxxe Assets fully exited HCA Healthcare in Q2 2026, selling an estimated $6.62M.
  • Oliver Luxxe Assets's ten largest holdings make up 19% of its $680M portfolio in Q2 2026.
  • Oliver Luxxe Assets opened 16 new positions and closed 17 in Q2 2026.
  • Oliver Luxxe Assets's portfolio value rose 1.9% quarter-over-quarter to $680M.

Based on Oliver Luxxe Assets's 13F filing for Q2 2026, filed 9 Jul 2026.